BioP2P Staff
The CDMO Scorpius Holdings has entered a strategic partnership with Beyond Imagination to use autonomous AI-powered humanoid robots to enhance biomanufacturing productivity and efficiency.
The partnership seeks to address the challenges posed by the increased demand for rapid-scale biomanufacturing and the limited supply of skilled labor. Beyond’s autonomous humanoids possess the ability to learn from and collaborate with human colleagues, continuously improving their capabilities.
AI robotics have been deployed in other industries, where they have shown the ability to learn new procedures and protocols. Beyond’s AI robotics platform has the potential to integrate into existing workflows in the biomanufacturing regulated environment, enhancing both efficiency and output.
One of the notable benefits of Beyond’s autonomous humanoids is their ability to operate nearly 24/7. Beyond’s proprietary AI technology also features Hive Mind capability, which allows their autonomous humanoids to share knowledge and improve collective intelligence to increase operational efficiency.
“This partnership marks a major advance in the integration of advanced AI robotics into vital sectors, setting the foundation for a future where technology and human expertise align to transform the biomanufacturing and pharmaceutical industries,” said Harry Kloor, executive co-founder and CEO of Beyond Imagination. “Together, we look forward to ushering in a new age of technological innovation in biomanufacturing, pharmaceutical manufacturing, and beyond.”
You can read the full release here.